Oxford Biomedica Names New Finance Chief
Oxford Biomedica (OXB.L) appointed Lucinda Crabtree as chief financial officer to succeed Stuart Paynter, effective Sept. 2.Crabtree previously held the CFO role in German biopharmaceutical company
MorphoSys Informs Nasdaq Stock Market of Delisting Plans After Novartis Merger
MorphoSys (MOR.F) notified the Nasdaq Stock Market of its plan to delist from the Nasdaq Global Market, according to a July 12 filing.The German biopharmaceutical company intends to notify the
MorphoSys Announces Voluntary Delisting From The Nasdaq Global Market, Expects That The Last Trading Day Will Be On Or About August 2, 2024
MorphoSys AG ((FSE: MOR, NASDAQ:MOR) today announced that it has formally notified the Nasdaq Stock Market of its intention to voluntarily delist its American Depositary Shares ("ADSs") from the
Press Release: MorphoSys Announces Voluntary Delisting From the Nasdaq Global Market
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market PLANEGG/MUNICH, Germany--(BUSINESS WIRE)--July 12, 2024-- MorphoSys AG (FSE: MOR; NASDAQ: MOR) today announced that it has
MorphoSys AG Announces Merger Squeeze-Out
Novartis Seeks Squeeze Out Approval at MorphoSys AGM
The management board of MorphoSys (MOR.F) received a request from Novartis (NOVN.SW) to convene an annual general meeting on Aug. 27 to approve the transfer of the remaining shares of the Germany-
MorphoSys Announces Voluntary Delisting From the Nasdaq Global Market
EQS-News: MorphoSys AG / Key word(s): DelistingMorphoSys Announces Voluntary Delisting from the Nasdaq Global Market 12.07.2024 / 22:02 CET/CESTThe issuer is solely responsible for the content of
Ad Hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
MorphoSys AG / Key word(s): Squeeze OutAd hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.0012-Jul-2024 / 14:34 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of
MorphoSys AG Clarifies Voting Rights Status
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating MorphoSys AG Buyout
Wilmington, Delaware--(Newsfile Corp. - June 27, 2024) - Rigrodsky Law, P.A. is investigating MorphoSys AG ("MorphoSys") (NASDAQ: MOR) regarding possible breaches of fiduciary duties and other violati
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading
European equities traded in the US as American depositary receipts were trending lower late Wednesday morning, falling 0.85% to 1,421.90 on the S&P Europe Select ADR Index. From continental Europe, th
MorphoSys In Delisting Agreement With Novartis
MorphoSys Delisting From Frankfurt Stock Exchange, Nasdaq Expected to Take Place in 3Q
MorphoSys Delisting From Frankfurt Stock Exchange, Nasdaq Expected to Take Place in 3Q
Novartis to Offer EUR68 a Share in Cash to Minority MorphoSys Shareholders
Novartis to Offer EUR68 a Share in Cash to Minority MorphoSys Shareholders
Novartis Holds Around 91.04% of MorphoSys as of Thursday
Novartis Holds Around 91.04% of MorphoSys as of Thursday
Ad Hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG's Minority Shareholders
PLANEGG and MUNICH, GERMANY / ACCESSWIRE / June 20, 2024 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announces that Novartis BidCo Germany AG informed the MorphoSys AG Management Board of its intention to me
MorphoSys to Leave Deutsche Börse's MDAX, TecDAX Indices
Deutsche Börse (DB1.F) said Tuesday that MorphoSys (MOR.F) will exit its MDAX and TecDAX indices, effective June 24. The biopharmaceutical company will leave the indices as its free float dropped bel
Express News | MorphoSys appoints nov inc executives as new CEO and CFO.
Ad Hoc: Arkadius Pichota and Lukas Gilgen Appointed to Management Board of MorphoSys AG Replacing the Current CEO and CFO
MorphoSys AG / Key word(s): PersonnelAd hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO06-Jun-2024 / 22:19 CET/CESTDisclosure of
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
European equities traded in the US as American depositary receipts were trending lower late Tuesday morning, declining 0.61% to 1,415.12 on the S&P Europe Select ADR Index. From continental Europe, th